Skip to main content


China Approves novel homegrown flu treatment, Onradivir

News Image

BEIJING: China's top drug regulator has approved a new homegrown flu treatment, onradivir, marking a significant addition to the global fight against influenza. This first-in-class innovative medicine targets a novel protein and is authorized for treating adult patients with uncomplicated influenza A.

The National Medical Products Administration announced the approval, stating that "The approval of this medication provides patients with a new treatment option."

Onradivir was jointly developed by Raynovent in Guangzhou, Guangdong province, the First Affiliated Hospital of Guangzhou Medical University, and leading respiratory disease research institutions.

According to China Daily, this medicine is the world's first anti-influenza drug to target the PB2 protein of the virus's RNA polymerase. Its developers claim the new medicine offers "rapid, potent and low-resistance efficacy," presenting a "Chinese solution to tackling global influenza epidemics."

Globally, influenza accounts for approximately 1 billion cases annually, including 3 to 5 million severe cases and an estimated 290,000 to 650,000 deaths each year.

Comments

Popular posts from this blog

Mohammad Hussain Khan   Published   June 15, 2025     Updated   about 5 hours ago     0 follow ahmadblogger56  HYDERABAD: The Hyderabad Cancer Registry inaugurated on Saturday at the Diagnostic and Research Laboratory in Liaquat University of Medical and Health Sciences revealed in its first findings that oral cancer topped the list among men and breast cancer among women. LUMHS Vice Chancellor Prof Dr Ikram Din Ujjan, who along with Prof Shahid Pervez, consultant histopathology, Aga Khan University, Karachi, opened the registry said that aim of inaugurating the registry was to collect data on cancer patients from all over Pakistan. He said the LUMHS in collaboration with Karachi Cancer Registry, Health Research Institute, National Institute of Child Health, Jinnah Postgraduate Medical Centre, Karachi, collected and analysed cancer data of all malignancies from Hyderabad Cancer Registry for 2020-2023 period in various age groups and genders t...
Russia-Ukraine direct talks: No ceasefire, but what did they agree to? Delegations in Istanbul agree swap of at least 1,000 prisoners, but a ceasefire remains out of reach. The Ukrainian delegation, led by Ukrainian Defence Minister Rustem Umerov, attends a meeting at Ciragan Palace on the day of the second round of peace talks between Russia and Ukraine, in Istanbul, Turkiye, on June 2, 2025 [Murad Sezer/Reuters] By  Al Jazeera Staff Published On 3 Jun 2025 3 Jun 2025 Save articles to read later and create your own reading list. Russia and Ukraine have agreed to a new prisoner swap and the return of thousands of dead soldiers during direct talks in Istanbul, although little headway was made towards ending the war. The rival delegations met on Monday at the Ottoman-era Ciragan Palace in the Turkish city, and officials confirmed that both sides will  exchange prisoners of war  and the remains of 6,000 soldiers killed in combat. RECOMMENDED STORIES list of 4 items list 1 of...
Pi Network 2025 Price Prediction: Will PI Coin Reach New Heights? As we approach 2025, anticipation continues to build around the future of the Pi Network and its native cryptocurrency, PI coin. Launched with the goal of creating a decentralized, user-friendly digital currency mined via mobile phones, Pi Network has garnered a large global following. But with mainnet developments still underway and limited exchange listings, the big question remains: What will the price of PI coin be in 2025? While precise predictions vary, several factors will influence PI's future value: Mainnet Launch & Exchange Listings : A full mainnet rollout and listings on major exchanges could significantly boost investor confidence and liquidity. Community Growth : With over 40 million users, Pi Network’s expanding community adds fundamental value. Regulatory Environment : Global crypto regulation in 2025 may impact PI’s adoption and market potential. Utility & Use Cases : The more prac...